Literature DB >> 16259742

Gastric bypass surgery does not increase susceptibility to Helicobacter pylori infection in the stomach of rat or mouse.

Björn Stenström1, Kirsti Løseth, Lars Bevanger, Erik Sturegård, Torkel Wadström, Duan Chen.   

Abstract

Gastric bypass is a clinical option for obesity surgery. An increased susceptibility to Helicobacter pylori infection in the bypassed stomach has been speculated. The aim of the present study was to examine the susceptibility of the bypassed stomach to H. pylori infection in rats and mice. Adult Sprague-Dawley and Wistar rats and NMRI mice were subjected to either gastric bypass or laparotomy only as control. The animals were inoculated with the CagA- and VacA- positive H. pylori strain 67/21 (not mouse-adapted) in the first experiment and with 9 additional isolates in the second, by injection into the bypassed stomach or the control stomach during surgery. The stomach of each animal was collected for H. pylori culture 2-3 weeks later. While all the rats were H. pylori negative, 54% of gastric bypassed mice and 75% of controls were positive (P = 0.4). We conclude that susceptibility to H. pylori infection in the stomach is not increased by gastric bypass surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16259742     DOI: 10.1163/156856005774423791

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  13 in total

1.  Investigation of the excluded stomach after Roux-en-Y gastric bypass.

Authors:  M Sundbom; R Nyman; H Hedenström; S Gustavsson
Journal:  Obes Surg       Date:  2001-02       Impact factor: 4.129

Review 2.  Obesity: epidemiology and possible prevention.

Authors:  Ian D Caterson; Timothy P Gill
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2002-12       Impact factor: 4.690

Review 3.  Helicobacter pylori and gastric diseases.

Authors:  M J Blaser
Journal:  BMJ       Date:  1998-05-16

4.  A rat model of chronic Helicobacter pylori infection. Studies of epithelial cell turnover and gastric ulcer healing.

Authors:  H Li; I Kalies; B Mellgård; H F Helander
Journal:  Scand J Gastroenterol       Date:  1998-04       Impact factor: 2.423

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

Review 6.  Role of therapy or monitoring in preventing progression to gastric cancer.

Authors:  Jaroslav Zivny; Timothy C Wang; Rhonda Yantiss; Kyung H Kim; JeanMarie Houghton
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

7.  Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery.

Authors:  Archana Ramaswamy; Edward Lin; Bruce J Ramshaw; C Daniel Smith
Journal:  Arch Surg       Date:  2004-10

Review 8.  The treatment of obesity.

Authors:  Winston C Mina; Richard W Burns; Boyd E Terry
Journal:  Mo Med       Date:  2003 May-Jun

9.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

10.  Gastric stapling for morbid obesity: gastrointestinal response in a rat model.

Authors:  E A Young; M M Taylor; M K Taylor; A S McFee; O L Miller; C A Gleiser
Journal:  Am J Clin Nutr       Date:  1984-08       Impact factor: 7.045

View more
  1 in total

1.  Can a short course of prophylactic low-dose proton pump inhibitor therapy prevent stomal ulceration after laparoscopic Roux-en-Y gastric bypass?

Authors:  Mathieu André D'Hondt; Hans Pottel; Dirk Devriendt; Frank Van Rooy; Franky Vansteenkiste
Journal:  Obes Surg       Date:  2010-01-08       Impact factor: 4.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.